| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de48b689b67bf3e1f33ccae4239e6150 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc36eba4b0fc351c00263d49960c35f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cafed7c615c52c476747368db582e89c |
| publicationDate |
2007-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007212438-A |
| titleOfInvention |
Cancer diagnostic agent and cancer diagnostic kit |
| abstract |
To find a novel marker for more accurately diagnosing cancer, particularly colorectal cancer and gastric cancer, a cancer diagnostic agent and a cancer diagnostic kit using the same, and a method for evaluating the severity and prognosis of cancer To provide. A cancer diagnostic agent and a cancer diagnostic kit comprising an antibody that recognizes tenascin-C polymer splicing variant, and a method for evaluating the severity of cancer and a method for prognosis thereof. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012015008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11693007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110612447-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019376976-A1 |
| priorityDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |